TY - JOUR
T1 - Age, race, diabetes, blood pressure, and mortality among hemodialysis patients
AU - Myers, Orrin B.
AU - Adams, Christopher
AU - Rohrscheib, Mark R.
AU - Servilla, Karen S.
AU - Miskulin, Dana
AU - Bedrick, Edward J.
AU - Zager, Philip G.
PY - 2010/11
Y1 - 2010/11
N2 - Observational studies involving hemodialysis patients suggest a U-shaped relationship between BP and mortality, but the majority of these studies followed large, heterogeneous cohorts. To examine whether age, race, and diabetes status affect the association between systolic BP (SBP; predialysis) and mortality, we studied a cohort of 16,283 incident hemodialysis patients. We constructed a series of multivariate proportional hazards models, adding age and BP to the analyses as cubic polynomial splines to model potential nonlinear relationships with mortality. Overall, low SBP associated with increased mortality, and the association was more pronounced among older patients and those with diabetes. Higher SBP associated with increased mortality among younger patients, regardless of race or diabetes status. We observed a survival advantage for black patients primarily among older patients. Diabetes associated with increased mortality mainly among older patients with low BP. In conclusion, the design of randomized clinical trials to identify optimal BP targets for patients with ESRD should take age and diabetes status into consideration.
AB - Observational studies involving hemodialysis patients suggest a U-shaped relationship between BP and mortality, but the majority of these studies followed large, heterogeneous cohorts. To examine whether age, race, and diabetes status affect the association between systolic BP (SBP; predialysis) and mortality, we studied a cohort of 16,283 incident hemodialysis patients. We constructed a series of multivariate proportional hazards models, adding age and BP to the analyses as cubic polynomial splines to model potential nonlinear relationships with mortality. Overall, low SBP associated with increased mortality, and the association was more pronounced among older patients and those with diabetes. Higher SBP associated with increased mortality among younger patients, regardless of race or diabetes status. We observed a survival advantage for black patients primarily among older patients. Diabetes associated with increased mortality mainly among older patients with low BP. In conclusion, the design of randomized clinical trials to identify optimal BP targets for patients with ESRD should take age and diabetes status into consideration.
UR - http://www.scopus.com/inward/record.url?scp=78149316872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78149316872&partnerID=8YFLogxK
U2 - 10.1681/ASN.2010010125
DO - 10.1681/ASN.2010010125
M3 - Article
C2 - 20947632
AN - SCOPUS:78149316872
SN - 1046-6673
VL - 21
SP - 1970
EP - 1978
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 11
ER -